You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adrenergic Alpha-Antagonists

Showing 1 - 25 of 4,199
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoidosis Trial (STOP arm)

Not yet recruiting
  • Sarcoidosis
  • STOP arm
  • (no location specified)
Jan 16, 2023

Insulin Resistance, Healthy, Obesity Trial in Nashville (Phentolamine, Saline, Sodium Nitroprusside)

Recruiting
  • Insulin Resistance
  • +2 more
  • Nashville, Tennessee
    Autonomic Dysfunction Center
Jan 2, 2023

Pheochromocytoma, Paraganglioma, Adrenalectomy; Status Trial in Seoul (Phenoxybenzamine)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 18, 2023

Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Infliximab: Adalimumab; Etanercept;
  • Sulaymaniyah, Kurdistan Region, Iraq
    Hiwa Khidhir Saaed
May 12, 2022

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Outcome Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Outcome
  • (no location specified)
Nov 28, 2023

Outcome Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Outcome
  • (no location specified)
Nov 28, 2023

Nocturia Trial in Birmingham, Atlanta (Behavioral, tamsulosin (alpha-adrenergic antagonist medication), )

Completed
  • Nocturia
  • Behavioral
  • +2 more
  • Birmingham, Alabama
  • +1 more
Sep 9, 2021

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)

Not yet recruiting
  • Opioid Use Disorder
  • Opioid Withdrawal
  • BXCL501 (180 micrograms)
  • +3 more
  • (no location specified)
Jan 24, 2023

Symptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease Trial in Los Angeles (Terazosin

Recruiting
  • Symptomatic Parkinson Disease
  • +2 more
  • Terazosin therapy
  • Los Angeles, California
    Cedars Sinai Medical Center
Aug 23, 2022

Healthy Volunteers Trial in New York (Clonidine Pill)

Withdrawn
  • Healthy Volunteers
  • Clonidine Pill
  • New York, New York
    Weill Cornell Medicine
Jul 14, 2021

Delirium, Cognitive Decline, Frailty Trial in Bergen, Oslo, Trondheim (Dexmedetomidine, Clonidine, Natriumchlorid)

Recruiting
  • Delirium
  • +2 more
  • Bergen, Norway
  • +3 more
Apr 25, 2022

Benign Prostatic Hyperplasia (BPH) Trial in France (REZUM, alpha blocker and 5-alpha reductase inhibitor)

Recruiting
  • Benign Prostatic Hyperplasia (BPH)
  • REZŪM
  • alpha blocker and 5-alpha reductase inhibitor
  • Aix-en-Provence, France
  • +9 more
Jul 26, 2022

ß1-adrenergic Antagonists on Nociceptive-Level Index Variation

Completed
  • Nociception During Anesthesia in Patients Taking β1-adrenergic Antagonist Chronic Treatment
  • standardized noxious stimulus under general anesthesia.
  • Montréal-Est, Quebec, Canada
    Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montre
Aug 31, 2020

Atrial Fibrillation, Atrial Fibrillation New Onset, Atrial Fibrillation, Persistent Trial in Canada (Cryoballoon-based PVI,

Active, not recruiting
  • Atrial Fibrillation
  • +12 more
  • Cryoballoon-based PVI
  • Anti-Arrhythmic Drug Therapy
  • Calgary, Alberta, Canada
  • +17 more
Aug 22, 2022

Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and

Not yet recruiting
  • Benign Prostatic Hyperplasia
  • Phosphodiesterase 5 Inhibitors
  • +2 more
  • (no location specified)
Feb 10, 2022

Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine)

Not yet recruiting
  • Scoliosis Correction
  • +4 more
  • Beijing, Beijing, China
    Beijing University First Hospital
Oct 17, 2023

Delirium Trial in Birmingham (Guanfacine, Placebo)

Recruiting
  • Delirium
  • Birmingham, Alabama
    University of Alabama at Birmingham Hospital
Nov 17, 2021

Benign Prostatic Hyperplasia Trial in Moscow (intermittent catheterization, trial without catheter, alpha-blockers)

Recruiting
  • Benign Prostatic Hyperplasia
  • intermittent catheterization
  • +2 more
  • Moscow, Russian Federation
    Moscow state university of medicine and dentistry named after A.
Oct 15, 2021

Anesthesia Intubation Complication Trial in Zagazig (Nebulized Dexmedetomidine, Nebulized Lidocaine, Intravenous

Not yet recruiting
  • Anesthesia Intubation Complication
  • Nebulized Dexmedetomidine
  • +3 more
  • Zagazig, Al-Sharkia, Egypt
    Faculty of medicine, Zagazig University
Jul 4, 2023